Chemometric characterization of s-triazine derivatives in relation to structural parameters and biological activity

Drug Development and Industrial Pharmacy

Volumn 36, Issue 8, 2010, Pages 954-961

  Djaković Sekuli, Tatjana L ^a   Smoliński, Adam ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b CENTRAL MINING INSTITUTE   (Poland)

Author keywords

HCA; PCA; PLS; QSAR; S triazines; Screening activity; Structure based design

Indexed keywords

2 PROPANOL; ACETONE; ACETONITRILE; METHANOL; TETRAHYDROFURAN; TRIAZINE DERIVATIVE; WATER; HERBICIDE; SOLVENT;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL BINDING; CHEMOMETRICS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; BIOLOGICAL MODEL; BIOLOGY; CHEMICAL PHENOMENA; CHEMISTRY; CLUSTER ANALYSIS; COMPARATIVE STUDY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; THIN LAYER CHROMATOGRAPHY;

CHROMATOGRAPHY, THIN LAYER; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; HERBICIDES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LEAST-SQUARES ANALYSIS; MODELS, BIOLOGICAL; PHYSICOCHEMICAL PHENOMENA; PRINCIPAL COMPONENT ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLVENTS; TRIAZINES;

EID: 77954203146     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903585168     Document Type: Article

References (22)

1. Martin H, Worthing CR. (1997). Pesticide manual. Nottingham: British Crop Protection Council.
2. Arya K, Dandia A. (2007). Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines. Bioorg Med Chem Lett, 17:3298-3304 doi:10.1016/jbmcl.2007.04.007.
3. Saczewski F, Bulakowska A. (2006). Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives. Eur J Med Chem, 41:611-615 doi:10.1016/j.ejmech.2005.12.012. (Pubitemid 43766803)
4. Srinivas K, Srinivas U, Bhanuprakash K, Harakishore K, Murthy USN, Jayathirtha Rao V. (2006). Synthesis and antibacterial activity of various substituted s-triazines. Eur J Med Chem, 41:1240-1246 doi:10.1016/j.ejmech.2006. 05.013. (Pubitemid 44666218)
5. Kaliszan R. (2007). QSRR: Quantitative structure-(chromato-graphic) retention relationships. Chem Rev, 107:3212-3246 doi:10.1021/cr068412z. (Pubitemid 47177110)
6. Nasal A, Siluk D, Kaliszan R. (2003). Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. Curr Med Chem, 10:381-426. doi: 10.2174/0929867033368268.
7. Kapetanovic IM. (2008). Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach. Chem Biol Interact, 171l:165-176 doi:10.1016/j.cbi.2006.12.006. (Pubitemid 351146652)
8. Bon1ic-Cari1ic GA, Jovanovic B, Jeremic DS. (1983). Electron impact mass spectrometry of some 2,4,6-substituted s-triaz-ines. Effect of a-and b-substitution. Int J Mass Spectrom Ion Phys, 47:455-458 doi:10.1016/0020- 7381(83)87232-5.
9. Bon1ic-Cari1ic GA, Tadic D, Jeremic DS. (1983). Electron impact mass spectrometry of some 2,4,6-substituted s-triaz-ines. Effect of the ring size. Int J Mass Spectrom Ion Phys, 47:451-454 doi:10.1016/0020-7381(83)87231-3.
10. Biagi GL, Barbaro AM, Sapone A, Recanatini M. (1994). Determination of lipophilicity by means of reversed-phase thin-layer chromatography: I. Basic aspects and relationship between slope and intercept of TLC equations. J Chromatogr A, 662:341-361 doi:10.1016/0021-9673(94)80521-0. (Pubitemid 24075191)
11. Cimpan G Hadaruga M Miclaus V.(2000) Lipophilicity characterization by reversed-phase liquid chromatography of some furan derivatives. J Chromatogr A, 869:49-55. doi:101016/S0021-9673(99)01202-9.
12. Vrakas D, Hadjipavlou-Litina D, Tsantili-Kakoulidou A. (2005). Retention of substituted coumarins using immobilized artificial membrane (IAM) chromatography: A comparative study with n-octanol partitioning and reversed-phase HPLC and TLC. J Pharm Biomed Anal, 39:908-913 doi:10.1016/j.jpba.2005.05.026. (Pubitemid 41441718)
13. Vieth M, Siegel MG, Higgs RE, Watson IA, Robertson DH, Savin KA, et al. (2004). Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem, 47:224-232 doi: 10.1021/jm030267j. (Pubitemid 38040506)
14. Proudfoot JR. (2005). The evolution of synthetic oral drug properties. Bioorg Med Chem Lett, 15:1087-1090 doi:10.1016/j.bmcl.2004.12.024. (Pubitemid 40467436)
15. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 23:3-25. doi:10.1016/S0169-409X(00)00129-0.
16. Joliffe IT. (1986). Principal components analysis. New York: Springer.
17. Wold S, Esbensen K, Geladi P. (1987). Principal component analysis. Chemom Intell Lab Syst, 2:37-52. doi:10.1016/0169-7439(87)80084-80089
18. Vandeginste BGM, Massart DL, Buydens LMC, De Jong S, Lewi PJ, Smeyers-Verbeke J. (1998). Handbook of chemometrics and qualimetrics: Part B. Amsterdam, the Netherlands: Elsevier, 87-150.
19. Martens H, Naes T. (1897). Multivariate calibration by data compression. In: Williams PC, Norris K, eds. Near-infrared technology in agricultural and food industries. St. Paul, MN: Am Assoc Cereal Chem, 57-87
20. Martens H, Naes T. (1989). Multivariate calibration. New York: John Wiley & Sons.
21. Wold S, Martens H, Wold H. (1983). The multivariate calibration problem in chemistry solved by the PLS method lecture notes in mathematics. Heidelberg: Springer Verlag.
22. Wold S. (1978). Cross-validatory estimation of the number of components in factor and principal component models. Tech-nometrics, 20:397-405.